6 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 1, 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Recruiting 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Ketanserin: new trials by email Literature Review of Ketanserin trials Research Report on Ketanserin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness Ketanserin 40mg plus Psilocybin 40mg, 40mg Psilocybin, 20mg Psilocybin - Healthy | Phase 1 | Recruiting | University Hospital, Basel, Switzerland | 16 | 2025-04-21 | 2025-05-28 |
| Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects LSD (150 µg) + ketanserin (40 mg), LSD (150 µg) + olanzapine (10 mg), LSD (150 µg) + lorazepam (2 mg) - Healthy | Phase 1 | Completed | University Hospital, Basel, Switzerland | 20 | 2024-02-01 | 2025-11-17 |
| Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness Placebo, Mescaline 100mg, Mescaline 200mg - Healthy | Phase 1 | Completed | University Hospital, Basel, Switzerland | 16 | 2021-08-11 | 2023-03-29 |
| Effect of Ketanserin After LSD Administration Lysergic Acid Diethylamide, Ketanserin Placebo, Ketanserin - Healthy | Phase 1 | Completed | University Hospital, Basel, Switzerland | 24 | 2020-10-16 | 2021-10-21 |
| Ketanserin Effects on Peripheral Temperature and Lactate Ketanserin, Placebo - Critical Illness | Phase 4 | Unknown | Onze Lieve Vrouwe Gasthuis | 120 | 2018-09-01 | 2018-08-24 |
| The Neurobiological Effect of 5-HT2AR Modulation Psilocybine, Ketanserin - Basic Science | Phase 1 | Recruiting | Gitte Moos Knudsen | 200 | 2017-03-03 | 2024-12-16 |
| The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers Placebo, LSD, Ketanserin - Healthy | Not applicable | Completed | Psychiatric University Hospital, Zurich | 25 | 2015-03-01 | 2016-02-01 |
| Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers Pirfenidone with MODD, Ketanserin - Diabetic Foot Ulcer | Phase 1 / Phase 2 | Completed | University of Guadalajara | 60 | 2014-01-01 | 2015-12-17 |
| The Effect of Ketanserin on the Microcirculation in Sepsis ketanserin - Severe Sepsis, Septic Shock | Phase 3 | Completed | Frisius Medisch Centrum | 10 | 2011-03-01 | 2014-05-09 |
| Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery fenoldopam (Corlopam), placebo, ketanserin (Sufrexal) - Acute Renal Failure | Phase 3 | Terminated | Medical University of Gdansk | 60 | 2008-04-01 | 2016-11-15 |
Acute Kidney Injury (1) · Critical Illness (1) · Diabetic Foot (1) · Sepsis (1) · Shock, Septic (1)
University Hospital, Basel, Switzerland (4) · Frisius Medisch Centrum (1) · Gitte Moos Knudsen (1) · Medical University of Gdansk (1) · Onze Lieve Vrouwe Gasthuis (1) · Psychiatric University Hospital, Zurich (1) · University of Guadalajara (1)
Switzerland (5) · Denmark (1) · Mexico (1) · Netherlands (1) · Poland (1)
E Boerma, MDPhD (1) · Franz X. Vollenweider, Prof. Dr. (1) · Gitte M Knudsen, Professor (1) · Juan Armendariz-Borunda, PhD, FAASLD (1) · Katarzyna Klajbor, MD (1) · Matthias E Liechti, Dr., MD (1) · Matthias E Liechti, Prof. Dr. MD (1) · Romuald Lango, MD, PhD (1)
PMID 30355445, PMID 34313217, PMID 36342343, PMID 39607014, PMID 40658345, PMID 42212900, PMID 42457666